Please Wait
Applying Filters...
menu
    • menu
    munit-sa-m-2025-04-14

    Virtual Booth

    Contact Supplier

    Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-04-14

    Virtual Booth

    Contact Supplier

    Menu

    Dimethyltryptamine

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    MARKET PLACE

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Atai Life Sciences Starts Phase 2 Trial of VLS-01 for Depression
    Atai Life Sciences Starts Phase 2 Trial of VLS-01 for Depression

    11 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/03/11/3040405/0/en/atai-Life-Sciences-Announces-First-Patient-Dosed-in-Elumina-the-Phase-2-Clinical-Trial-of-VLS-01-for-Treatment-Resistant-Depression.html

    GLOBENEWSWIRE
    11 Mar 2025
    Share Share
    atai Life Sciences Announces First Subject Dosed in Phase 1 Trial
    atai Life Sciences Announces First Subject Dosed in Phase 1 Trial

    05 Oct 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/10/05/2528522/0/en/atai-Life-Sciences-Announces-First-Subject-Dosed-in-Phase-1-Trial-of-Buccal-and-IV-VLS-01-a-Synthetic-Form-of-DMT.html

    GLOBENEWSWIRE
    05 Oct 2022
    Share Share
    Core One Labs' Scientists Successfully Complete Breakthrough in Producing API
    Core One Labs' Scientists Successfully Complete Breakthrough in Producing API

    02 Sep 2022

    // ACCESSWIRE

    https://www.accesswire.com/viewarticle.aspx?id=714615

    ACCESSWIRE
    02 Sep 2022
    Share Share
    Cybin completes purchase of anxiety disorder treatment study
    Cybin completes purchase of anxiety disorder treatment study

    12 Jul 2022

    // CLINICALTRIALSARENA

    https://www.clinicaltrialsarena.com/news/cybin-anxiety-disorder-treatment-study/

    CLINICALTRIALSARENA
    12 Jul 2022
    Share Share
    Small Pharma Reports Fiscal Third Quarter 2021 Highlights
    Small Pharma Reports Fiscal Third Quarter 2021 Highlights

    31 Jan 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/01/31/2376167/0/en/Small-Pharma-Reports-Fiscal-Third-Quarter-2021-Highlights.html

    GLOBENEWSWIRE
    31 Jan 2022
    Share Share
    Algernon Discloses Novel Salt Patent Strategy as Part of Psychedelic Drug DMT IP
    Algernon Discloses Novel Salt Patent Strategy as Part of Psychedelic Drug DMT IP

    24 Jan 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/01/24/2371542/0/en/Algernon-Pharmaceuticals-Discloses-Novel-Salt-Patent-Strategy-as-Part-of-its-Psychedelic-Drug-DMT-Intellectual-Property.html

    GLOBENEWSWIRE
    24 Jan 2022
    Share Share